ClearPoint Neuro, Inc. Quarterly report pursuant to sections 13 or 15(d)

Quarterly report pursuant to sections 13 or 15(d)

Note 5 - Stockholders' Equity (Tables)

Note 5 - Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2013

Stockholders' Equity Note [Abstract]

	January 2013 Financing Transaction Date			September 30, 2013
Dividend yield		0%			0%
Expected volatility	47.08%	-	100.00%	45.96%	-	100.00%
Risk free interest rates		0.91%		0.93%	-	1.14%
Expected remaining term (years)		5		3.76	to	4.32

Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]

Balance at January 1, 2013	$	2,128,302
Fair value of warrants issued in January 2013
Financing Transaction at transaction date		3,305,245
Decrease in fair value resulting in gain		(1,327,323	)
Fair value at September 30, 2013	$	4,106,224

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Shares			Weighted - Average Exercise Price
Outstanding at January 1, 2013		6,432,127		$	1.58
Granted		452,500			1.20
Forfeited		(144,750	)		2.18
Outstanding at September 30, 2013		6,739,877			1.54

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Dividend yield		0%
Expected Volatility	45.33%	to	45.96%
Risk free Interest rates	0.92%	to	1.96%
Expected lives (years)	5.5	to	6.0

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

Three Months Ended September 30,				Nine Months Ended September 30,
2013		2012		2013		2012
$	345,632	$	300,304	$	988,223	$	843,866

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

	Shares			Weighted - Average Exercise Price
Outstanding at January 1, 2013		8,763,836		$	0.95
Issued		4,643,842			1.75
Forfeited		(41,666	)		1.00
Exercised		(1,162,523	)		0.10
Outstanding at September 30, 2013		12,203,489			1.33

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details